These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 907536)

  • 1. Brain dopamine turnover and the relief of parkinsonism.
    Rinne UK; Marttila R; Sonninen V
    Arch Neurol; 1977 Oct; 34(10):626-9. PubMed ID: 907536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain dopamine turnover and the relief of parkinsonism.
    Rinne UK; Sonninen V; Marttila R
    Adv Exp Med Biol; 1977; 90():267-75. PubMed ID: 930747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic agonist effects on Parkinsonian clinical features and brain monamine metabolism.
    Rinne UK; Sonninen V; Marttila R
    Adv Neurol; 1975; 9():383-92. PubMed ID: 1096575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic mechanisms in patients with extrapyramidal disease.
    Chase TN; Shoulson I
    Adv Neurol; 1975; 9():359-66. PubMed ID: 1146660
    [No Abstract]   [Full Text] [Related]  

  • 5. Brain dopamine receptor stimulation and the relief of Parkinsonism: relationship between bromocriptine and levodopa.
    Rinne UK; Marttila R
    Ann Neurol; 1978 Sep; 4(3):263-7. PubMed ID: 718139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin and dopamine disturbances in patients with unipolar depression and Parkinsonism.
    Mendlewicz J; Vanderheyden JE; Noel G
    Adv Exp Med Biol; 1981; 133():753-67. PubMed ID: 6172024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic nervous transmission in Parkinson's disease.
    Rinne UK; Sonninen V; Riekkinen P; Laaksonen H
    Med Biol; 1974 Jun; 52(3):208-17. PubMed ID: 4371255
    [No Abstract]   [Full Text] [Related]  

  • 8. Central monoamine metabolism in man. Effect of putative dopamine receptor agonists and antagonists.
    Chase TN
    Arch Neurol; 1973 Nov; 29(5):349-51. PubMed ID: 4270339
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronic, multiple tics of Gilles de la Tourette's disease. CSF acid monoamine metabolites after probenecid administration.
    Cohen DJ; Shaywitz BA; Caparulo B; Young JG; Bowers MB
    Arch Gen Psychiatry; 1978 Feb; 35(2):245-50. PubMed ID: 272137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a dopamine agonist piribedil in depressed patients: relationship of pretreatment homovanillic acid to antidepressant response.
    Post RM; Gerner RH; Carman JS; Gillin JC; Jimerson DC; Goodwin FK; Bunney WE
    Arch Gen Psychiatry; 1978 May; 35(5):609-15. PubMed ID: 215097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and pharmacological evaluation of the effects of piribedil in patients with parkinsonism.
    McLellan DL; Chalmers RJ; Johnson RH
    Acta Neurol Scand; 1975 Jan; 51(1):74-82. PubMed ID: 1091122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid probenecid studies: a reinterpretation.
    Cowdry RW; Ebert MH; van Kammen DP; Post RM; Goodwin FK
    Biol Psychiatry; 1983 Nov; 18(11):1287-99. PubMed ID: 6197100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3,4-Dihydroxyphenylethylamine and 5-hydroxytryptamine metabolism in the rat: acidic metabolites in cisternal cerebrospinal fluid before and after giving probenecid.
    Curzon G; Hutson PH; Kantamaneni BD; Sahakian BJ; Sarna GS
    J Neurochem; 1985 Aug; 45(2):508-13. PubMed ID: 2409231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Central metabolism of dopamine and serotonin. II. Significance of cerebrospinal fluid HVA and 5-HIAA changes in extrapyramidal and cerebellar syndromes].
    Buscaino GA; Mandarini A; Campanella G; Carrieri P; Orefice G
    Acta Neurol (Napoli); 1976; 31(5):565-70. PubMed ID: 138340
    [No Abstract]   [Full Text] [Related]  

  • 15. Dopamine and depression: a review of recent evidence. I. Empirical studies.
    Willner P
    Brain Res; 1983 Dec; 287(3):211-24. PubMed ID: 6140979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 14C-homovanillic acid in the cerebrospinal fluid of parkinsonian patients after intravenous 14C-L-dopa.
    Extein I; Van Woert M; Roth RH; Bowers MB
    Biol Psychiatry; 1976 Apr; 11(2):227-32. PubMed ID: 971447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of valproic acid on the 5-hydroxyindoleacetic, homovanillic and lactic acid levels of cerebrospinal fluid.
    MacMillan V; Leake J; Chung T; Bovell M
    Brain Res; 1987 Sep; 420(2):268-76. PubMed ID: 2445434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Central metabolism of dopamine and serotonin. I. Determination of cerebrospinal fluid levels of HVA and 5-HIAA by the probenecid test (modified)].
    Carrieri P; Campanella G; Mandarini A; Orefice G; Buscaino GA
    Acta Neurol (Napoli); 1976; 31(5):558-64. PubMed ID: 1015382
    [No Abstract]   [Full Text] [Related]  

  • 19. Biogenic amine disturbances in cerebrospinal fluid in parkinsonism and unipolar depression: use of the probenecid method.
    Vanderheyden JE; Noel G; Mendlewicz J
    Neuropsychobiology; 1981; 7(3):137-51. PubMed ID: 6164951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bromocriptine markedly suppresses levodopa-induced abnormal increase of dopamine turnover in the parkinsonian striatum.
    Ogawa N; Tanaka K; Asanuma M
    Neurochem Res; 2000 Jun; 25(6):755-8. PubMed ID: 10943992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.